Filing Flows › Option Care Health (OPCH) › Q3 2026
Option Care Health (OPCH) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 4, 2026
Option Care Health (OPCH) reported revenue of $1.5B for the third quarter 2026 (Q3 2026), +4% from a year earlier and +4% from the quarter before. Operating margin was 6.0%, net earnings $57.4M (3.8% of revenue).
Option Care Health, Q3 2026: revenue $1.5B (+4% year over year), operating margin 6.0%, net earnings $57.4M, operating cash flow $115M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | +4% | +4% |
| Gross profit | $285M | +7% | +4% |
| Operating profit | $89.2M | +5% | +6% |
| Net earnings | $57.4M | +7% | +11% |
| Operating cash flow | $115M | -38% | -18% |
| Free cash flow | $108M | -37% | -17% |
What changed
Revenue was $1.5B in Q3 2026, up 4% year over year and up 4% from the previous quarter.
Gross margin was 19.1%, up 0.1 points from Q3 2025. Operating profit was $0.09B, a 6.0% margin (up 0.1 points year over year). Of the extra revenue versus Q3 2025, 8% reached operating profit, above the 6% margin then. Operating expenses grew 4% against revenue growth of 4%. The fastest-growing cost line was Other operating costs (+11%). Net earnings were $0.06B, up 11% year over year. The effective tax rate was 27.2%.
Operating cash flow was $0.11B (down 18% year over year), 200% of net earnings. Non-cash charges added back $0.02B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items added $0.03B. Capital expenditures of $0.01B left free cash flow of $0.11B.
Questions
What was Option Care Health's revenue in the third quarter 2026?
Option Care Health (OPCH) reported revenue of $1.5B for the third quarter 2026 (Q3 2026), +4% from a year earlier and +4% from the quarter before.
Was Option Care Health profitable in the third quarter 2026?
Operating profit was $89.2M (6.0% of revenue) and net earnings $57.4M.
Source: Option Care Health 10-Q on SEC EDGAR.